NanGenex Announce Global Launch of NanoActive
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
NanGenex Inc. (formerly known as ComErgen) announced the global launch of its NanoActive. “The NanoActive™ technology provides nanoformulation solutions for original as well as generic applications in a wide variety of industries including pharmaceuticals, agrochemicals, cosmetics, foods, nutraceu home care.
“The proprietary NanoActive™ technology available top-down milling and high pressure homogenization based technologies. It is a bottom flow nano precipitation method for the synthesis of nanoparticles. The properties of the produced nanoparticles can be modified during the process by the precise control and optimization of various reaction parameters by as much as 90%”
The NanGenex partners acquire a license to the commercialize the NanoActive™ product or product families developed through the collaboration. In 2009, NanGenex expanded its patented including antihypertensives, cholesterol reducers, anti The NanoPharmaActive™ formulations have undergon the parent active molecules.
NanGenex explains that it is in advanced discussions with leading pharmaceutical a partnerships and strategic alliances for the development of novel nano. The drug nanoformulations can increase drug potency and reduce side effects. This brings clinically meaningful benefits to patients.
“The proprietary NanoActive™ technology available top-down milling and high pressure homogenization based technologies. It is a bottom flow nano precipitation method for the synthesis of nanoparticles. The properties of the produced nanoparticles can be modified during the process by the precise control and optimization of various reaction parameters by as much as 90%”
The NanGenex partners acquire a license to the commercialize the NanoActive™ product or product families developed through the collaboration. In 2009, NanGenex expanded its patented including antihypertensives, cholesterol reducers, anti The NanoPharmaActive™ formulations have undergon the parent active molecules.
NanGenex explains that it is in advanced discussions with leading pharmaceutical a partnerships and strategic alliances for the development of novel nano. The drug nanoformulations can increase drug potency and reduce side effects. This brings clinically meaningful benefits to patients.
